FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes a composition comprising one or more corticosteroids and/or hormonal steroids in the range from 0.025 to 5 wt.-% of the total composition mass and hyaluronidase in the amount from 25 to 4000 UTR per 1 g of the composition in the suitable carrier medium. The composition can comprise nonhormonal anti-inflammatory agents. The composition can be prepared in different medicinal formulations, such as gel, ointment, cream, aerosol with additives known from a person skilled in the art of the corresponding field. Betamethasone is the preferable corticosteroid. Ointment is the preferable medicinal formulation. Treatment by using corticosteroids in combination with hyaluronidase provides the improvement of state in 90% of patients, and after their treatment their prepuce can be drawn off easily.
EFFECT: improved medicinal properties of composition, enhanced effectiveness of treatment.
11 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION POSSESSING ANTI-ALLERGIC AND ANTI-INFLAMMATORY EFFECT | 2004 |
|
RU2281102C2 |
| METHOD FOR MEASURING REMOVED FORESKIN SIZE IN PHIMOSIS AND INSTRUMENT FOR IMPLEMENTING THEREOF | 2009 |
|
RU2417058C1 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING COMBINATION OF FUSIDIC ACID AND CORTICOSTEROID | 2008 |
|
RU2470645C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING VITAMIN D AND CORTICOSTEROID | 2007 |
|
RU2452488C2 |
| PHARMACEUTICAL COMPOSITION ELICITING ANTI-INFLAMMATORY AND ANTI-ALLERGIC EFFECT | 2002 |
|
RU2225208C1 |
| COMBINATIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2002 |
|
RU2300379C2 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS | 2020 |
|
RU2742879C1 |
| METHOD FOR SURGICAL CORRECTION OFERECTILE DEFORMATION IN CASE OF PEYRONIE'S DISEASE | 2002 |
|
RU2234257C2 |
| PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2238734C2 |
| METHOD OF PERFORMING CIRCUMCISION OPERATION | 2013 |
|
RU2567817C2 |
